Provided is a compound of Formula (I), and tautomers, stereoisomers, mixtures of tautomers or stereoisomers, pharmaceutically acceptable salts, or solvates thereof, with specified substituents. The compounds are useful in treating various hyperproliferative diseases modulated by MEK cascade or related to hyperactivity of MEK.